Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.090 CHF
−43.21 M CHF
26.90 M CHF
94.07 M
About FibroGen, Inc
Sector
Industry
CEO
Thane Wettig
Website
Headquarters
San Francisco
Founded
1993
FIGI
BBG00LVDC0C3
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
FGEN Trade Setup for Monday!🔻 **Stop Loss (SL):** Below **0.5400**
📈 **Entry:** Above **0.5783**
🎯 **Target 1 (T1):** **0.6197**
🎯 **Target 2 (T2):** **0.6669**
💡 **Why Trade:**
Triangle breakout with bullish continuation and volume supporting the move.
✅ **Conclusion:**
Defined risk-reward; monitor breakout st
FibroGen Has Great Technicals and FundamentalsI really like the technicals of this stock, we have nice over sold conditions with huge volume coming to accumulate. There is a huge gap above and I have set my targets on $6, $13 and $18 respectively. This is a larger time frame and potentially could take time to play out. I have attached an articl
FGEN A Biotechnology Penny running to earnings LONGFGEN has been uptrending for two weeks. In November's earnings it beat on revenue and
burned less cash than projected. Another earnings report is impending. On the 30 minute
chart, price has pumped 250%. The volume is okay but is not showing a rise and the price
volume trend is flat. This
FGEN - Free FallingTriple split screen analysis.
LEFT SCREEN:
FGEN broke support at $16.30 (white) and $9.20 (yellow) levels.
Currently it's at 47 cents and in what I refer to as, "no man's land."
It's "no man's land" because there's no support below it to keep price from falling further.
Could price reverse? Sure
FGEN Fibrogen Bottomed?Hi all.
Just an idea, not financial advice. :)
Looks like the FiboGen has reached its lowest level so far and to go 0 is not much left :)
seen the previous highs I think it is a good investment at the moment, with a low risk/high profit ratio in the long term, don't expect this to shoot up in a str
Up tnend startThe stock broke through resistance and went to close the gap. The global target is $24. Upside +50%. Trade with a trailing stop.
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . . . . . . Hit the 👍 LIKE button,
. . . . . . . . .
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1FG is 0.270 CHF — it has decreased by −17.93% in the past 24 hours. Watch FIBROGEN INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange FIBROGEN INC stocks are traded under the ticker 1FG.
1FG stock hasn't changed in a week, the last month showed zero change in price, over the last year FIBROGEN INC has showed a −17.93% decrease.
We've gathered analysts' opinions on FIBROGEN INC future price: according to them, 1FG price has a max estimate of 8.95 CHF and a min estimate of 8.95 CHF. Watch 1FG chart and read a more detailed FIBROGEN INC stock forecast: see what analysts think of FIBROGEN INC and suggest that you do with its stocks.
1FG stock is 21.85% volatile and has beta coefficient of 0.74. Track FIBROGEN INC stock price on the chart and check out the list of the most volatile stocks — is FIBROGEN INC there?
Today FIBROGEN INC has the market capitalization of 27.73 M, it has increased by 4.19% over the last week.
Yes, you can track FIBROGEN INC financials in yearly and quarterly reports right on TradingView.
FIBROGEN INC is going to release the next earnings report on Aug 11, 2025. Keep track of upcoming events with our Earnings Calendar.
1FG earnings for the last quarter are 0.04 CHF per share, whereas the estimation was 0.03 CHF resulting in a 66.67% surprise. The estimated earnings for the next quarter are −0.07 CHF per share. See more details about FIBROGEN INC earnings.
FIBROGEN INC revenue for the last quarter amounts to 2.39 M CHF, despite the estimated figure of 1.42 M CHF. In the next quarter, revenue is expected to reach 2.39 M CHF.
1FG net income for the last quarter is 4.11 M CHF, while the quarter before that showed 16.33 M CHF of net income which accounts for −74.85% change. Track more FIBROGEN INC financial stats to get the full picture.
No, 1FG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2025, the company has 225 employees. See our rating of the largest employees — is FIBROGEN INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FIBROGEN INC EBITDA is −24.76 M CHF, and current EBITDA margin is −433.04%. See more stats in FIBROGEN INC financial statements.
Like other stocks, 1FG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FIBROGEN INC stock right from TradingView charts — choose your broker and connect to your account.